Filing Details

Accession Number:
0001209191-21-060759
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-18 18:55:57
Reporting Period:
2021-10-14
Accepted Time:
2021-10-18 18:55:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1641217 Karl Dennis Huang C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Evp & Chief Tech Ops Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-14 358 $81.14 40,148 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
  2. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.